Robust regression for high throughput drug screening
Related Experiment Video
Updated: Aug 9, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Igor Fomenko1, Mark Durst, David Balaban
1Systems Informatics Department, Amgen, One Amgen Center Drive, MS 34-2-A, Thousand Oaks, CA 91320-1799, USA. ifomenko@amgen.com
Abstract:
Effective analysis of high throughput screening (HTS) data requires automation of dose-response curve fitting for large numbers of datasets. Datasets with outliers are not handled well by standard non-linear least squares methods, and manual outlier removal after visual inspection is tedious and potentially biased. We propose robust non-linear regression via M-estimation as a statistical technique for automated implementation. The approach of finding M-estimates by Iteratively Reweighted Least Squares (IRLS) and the resulting optimization problem are described. Initial parameter estimates for iterative methods are important, so self-starting methods for our model are presented. We outline the software implementation, done in Matlab and deployed as an Excel application via the Matlab Excel Builder Toolkit. Results of M-estimation are compared with least squares estimates before and after manual editing.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Drug Discovery: Overview

